Medication for Dementia (Acetylcholinesterase Inhibitors)

Similar documents
Aricept, Exelon and Reminyl the new drugs for Alzheimer s disease

If you have dementia, you may have some or all of the following symptoms.

Understanding Dementia

This information explains the advice about supporting people with dementia and their carers that is set out in NICE SCIE clinical guideline 42.

Medications for Alzheimer s disease: are they right for you?

Drug treatments for Alzheimer s disease

Understanding dementia

Dual Diagnosis Street Team

Effective Shared Care Agreement (ESCA) for drugs used in dementia- Donepezil, Galantamine, Rivastigmine and Memantine

Resources: Types of dementia

Dementia Support. Your guide to local support in the Royal Borough of Greenwich. Royal Borough of Greenwich May Supported by

What is dementia? Symptoms. alzheimers.org.uk

Shared Care Agreement for Donepezil

EFFECTIVE SHARED CARE AGREEMENT (ESCA)

Prescribing Framework for Rivastigmine in the Treatment and Management of Dementia

Cambridgeshire Community Services NHS Trust: delivering excellence in children and young people s health services

Dr Georgina Train Consultant Psychiatrist EMDASS service and Continuing Care.

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Duloxetine. For the Treatment of Pain

What is Alzheimer s disease

What is dementia? alzheimers.org.uk

Coping with breathlessness. Community Respiratory Team

Essential Shared Care Agreement Drugs for Dementia

Clozapine an introduction to treatment

NICE Quality Standards and commissioning dementia care

Dementia & carers: workers. Supporting dementia workers. A case study-based manager s guide to good practice in learning and development for social

Shared Care Agreement for Donepezil, Galantamine, Rivastigmine and Memantine

Prescribing Framework for Galantamine in the Treatment and Management of Dementia

Novel oral anticoagulant therapy (NOAC)

Drugs used to relieve behavioural and psychological symptoms in dementia

Dementia Carer s factsheet

SHARED CARE PROTOCOL CHOLINESTERASE INHIBITORS IN ALZHEIMER S DEMENTIA

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Current Treatments for Dementia and Future Prospects. James Warner St Charles Hospital, London

Delirium Information for relatives, carers and patients

Tel: or

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

Useful sources of information Pharmacy Medicines Helpline British Acupuncture Council British Medical Acupuncture Society Your comments and concerns

CAMHS. Your guide to Child and Adolescent Mental Health Services

Primary Care Prescribing Protocol to Support the Diagnosis and Management of People with Dementia

Getting Up From The Floor After a Fall. Cambridgeshire and Peterborough Falls Prevention Services

This is a legal requirement and will be discussed with you. All LJMC services are offered free of charge to NHS. Vernon Cancer Centre.

Older People s Community Mental Health Team

Ceritinib (Zykadia )

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

Alzheimer s disease. The facts in brief

Peterborough Nalmefene Pathway Responsibilities for Specialist Services & GP

Alzheimer Disease Agents Drug Class Prior Authorization Protocol

Improving Dementia Services in Northern Ireland. A Regional Strategy

Community Pharmacy Dementia Audit

Alzheimer s disease Treatment options

The Psychiatric Liaison Team for Older Adults

Dementia Alistair Burns National Clinical Director for Dementia

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Adult ADHD Service Patient Information Leaflet

Technology appraisal guidance Published: 23 March 2011 nice.org.uk/guidance/ta217

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

Tranexamic acid. Information for parents and carers

Alectinib (Alecensa ) Alectinib (Alecensa )

Donepezil, Galantamine, Rivastigmine and Memantine

2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust

Essential Shared Care Agreement Drugs for Dementia

Gabapentin. Information for Pain Clinic patients

Electroconvulsive Therapy (ECT) Patient Information Leaflet

What is dementia? What is dementia?

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer s disease (amended)

Atrial Fibrillation and Anticoagulants

Lambeth Early Onset (LEO) Team

Leflunomide Treatment Rheumatology Patient Information Leaflet

Tranexamic acid. Information for parents and carers

Electroconvulsive Therapy (ECT) Patient Information Leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

Myeloma Haematology and Transplant Unit CTD1

Medicines to treat pain in adults. Information for patients and carers

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Spinal cord compression: what it means and how it can be treated

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

The treatment of bipolar disorder in adults, children and adolescents

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Carbamazepine. For the Treatment of Pain

Electro-convulsive Therapy (ECT) Your questions answered

What is frontotemporal dementia?

Relaxation and wellbeing

Memory Loss, Dementia and Alzheimer's Disease: The Basics

A new model for prescribing varenicline

Strong opioids for palliative care patients

Your child s prednisolone. This leaflet is for parents of children taking prednisolone to treat their inflammatory condition.

Myeloma Haematology and Transplant Unit

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

Donepezil, Rivastigmine and Galantamine (TLS Amber with shared care) Donepezil (TLS green Wilts)

Duloxetine for the treatment of pain

Welcome to the Community Children and Young People s Service. Information you will find useful during your contact with the service

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

Mild memory problems

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

SHARED CARE GUIDELINE

2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust

What is dementia with Lewy bodies?

Transcription:

Medication for Dementia (Acetylcholinesterase Inhibitors) ^ ãéãäéê çñ `~ãäêáçöé råáîéêëáíó eé~äíü m~êíåéêë

What are they? A group of medications used to help treat the symptoms of dementia in the mild to moderate stages. Occasionally they may be used in the later stages of dementia following a clinical assessment. However, most people would not expect to stay on these tablets for life. The symptoms associated with dementia are believed to be related to a lack of a substance called acetylcholine in the brain, which is resposible for sending messages between brain cells. Acetylcholinesterase inhibitors work by incresing the amount of acetylcholine in the brain. It is usual to start on a low dose which is gradually increased. Alternative medication for dementia may be used if the person is experiencing many side effects. For example Memantine (please see separate information leaflet). The medication needs to be taken regularly as instructed to have the best effect. What they are called? Acetylcholinesterase inhibitors is a collective name for the medications listed below and may be abbreviated to AChEls. You may see several medicines under this heading, and these include- Donepezil (Aricept) Tablets and orodispersible tablets. Dosage 5mgs 10mg daily Galantamine (Reminyl XL) Tablets, capsules and liquid. Dosage 8mgs 24 mg once daily Rivastigmine (Exelon) Tablets and liquid. Dosage 1.5mgs - 6mgs twice daily. Transdermal patches. Dosage 4.6mg or 9.5mg once daily

Who prescribes? Medication for dementia should only be started by a specialist medical practitioner following thorough assessment adhering to NICE guidelines (National Institute for Health and Clinical Excellence). These clearly recommend that both patient and carers views should be taken into account. Before starting on medication for dementia your doctor is likely to request blood tests and possible further physical investigations such as an ECG (heart recording) or a CT scan (brain scan). Medications for dementia are not suitable for everyone and the prescribing doctor will require a detailed medical history (provided by your GP) and a list of all the medications you are currently taking. These will include both prescribed and 'over the counter preparations'. Benefits Research shows that about 50% - 60% of people, when prescribed medication for dementia show some improvement or stay the same. Some people have said that they feel more alert, brighter in mood and more motivated/active. This improvement may be maintained for some time or only a few weeks. The benefit of taking this medication may not be immediately apparent to you but a clinican may notice a hidden positive effect. The medication may help you to manage your memory changes and more effectively cope with day to day living.

What they won t do Common side effects Reverse the underlying processes causing dementia Maintain improvement of memory and function indefinitely. Extend life Side effects Side effects should reduce after a few weeks. If you are concerned about side effects do contact your doctor and if you experience episodes of faintness or falls it is advisable to seek medical advice straight away. Reduced appetite Nausea /vomiting Weight loss Stomach discomfort and diarrhoea Headaches/dizziness Sleep disturbance/fatigue Palpitations Skin irritation/rashes Function and behaviour affected in a negative way ie: increased agitation and/or challenging behaviours On rare occassions urinary retention and seizures have been reported. It is best to plan a quiet day the first time you take the medication so if you do experience any side effects you can remain at home and seek medical advice if necessary.

Monitoring When started on medication for dementia you will be regularly reviewed by a health practitioner while you are stabilised. You may then expect to have followup reviews on a six monthly basis by either a specialist service practitioner or a clinician from the GP practice where you are registered. Always make any new medical practitioners you see aware of the medication for dementia you are being prescribed as some medications should not be taken together. When are they no longer helpful? Stopping these medications may be considered if on assessment by a health practitioner The medication for dementia does not seem to have had any useful effect on the progression of the dementia Side effects are outweighing the benefits Behaviour has become altered in a negative or problematic way An individual has difficulty with remembering to take the medication regularly The dementia has progressed to a stage when the medication is no longer useful

Alternative management strategies for dementia Try to eat a nutritionally balanced diet and maintain a healthy lifestyle - stop smoking and reduce alcohol consumption Take regular exercise- at least 30 minutes daily is recommended Keep busy with activities which promote independence - helping with tasks around the home/ garden Keep Stimulated - with games, reading, crosswords, puzzles etc. Socialise - maintain your social life. Keep orientated buy a daily paper, use a diary, keep up to date. Maintain existing routines as much as possible Use validation therapy a method of communicating which respects and values the reality of the persons own experience/ feelings Use other therapies - relaxation, dance, music, pets Access anxiety management Make use of alternative therapies - aromatherapy and massage Access carer support Use assistive technology/ occupational therapy aids and memory prompts Avoid criticism and try to create a calm environment Access problem solving and skills training Accesss help and support in the home Access locally based support services Accesss support with decision making Access respite care Access residential and nursing care Accesss advocacy support and advice Fact sheets regarding these treatments are available from www.alzheimers.org.uk/factsheets Telephone: 0845 3000 336 www.ageuk.org.uk/publications Telephone: 08001696 565

Useful contacts Alzheimer s Society- For support and guidance with all types of memory impairment Cambridge locality office Tel 01223 884031 Peterborough Office Tel 01733 893853 Helpline (8.30am 6.30pm Mon-Fri) Tel 0845 3000 336 - Website www.alzheimers.org.uk Age UK Cambridgeshire South Cambridgeshire Office Tel 01223 221921 North Cambridgeshire Office Tel 01354 696677 Peterborough Office 01733 564185 Age UK Advocacy Service Office - Tel 01354 696541 Crossroads Support and Respite for Carers Tel 01223 415600 Social Services Cambridgeshire Direct Tel 0345 0455 202 Peterborough Direct Tel 01733 747474 Information Services Website www.cambridgeshire.net Those people not eligible for a Social Care Package of Support, can access services offered through Your Life Your Choice website, which supports people to remain independent in the community. Care Quality Commission Tel 0300 0616 161 Website www.cqc.org.uk Citizens Advice Bureaux Tel 0844 8487979 Website www.adviceguide.org.uk Lifeline-evening mental health helpline Tel 0808 808 2121 (7pm-11pm) Carers UK- Ely and Cambridge Tel 01353 663928 Huntingdon Tel 01480 420615 Carers Centre Peterborough Tel 01733 342683

References NHS Choices National Institute for Health and Clinical Excellence With many thanks to the Alzheimers Society Co-ordinator, Wendy Dunn, the service users and carers for their help with compiling this leaflet. British National Formulary NICE guidelines Ref TA 217 January 2011 (National Institute for Health and Clinical Excellence) Website www.nice.org.uk/guidelines If you have any concerns about any of CPFT's services, or would like more information please contact our Patient Advice and Liaison Service (PALS) on: freephone: 0800 376 0775 e-mail: pals@cpft.nhs.uk This information leaflet was written by Carolyn Fuller and Karen Moore, Clinical Nurse Practitioners. CPFT out-of-hours helpline Contact Lifeline on 0808 808 2121 7pm-11pm 365 days a year Updated 2016 en Elizabeth House, Fulbourn Hospital, Cambridge CB21 5EF. q 01223 219400 c 01480 398501 ïïïkåéñíkåüëkìâ